Cleared Traditional

K881124 - ALLEGRO(TM) LUTEINIZING HORMONE IMMUNOA...

K881124 is the FDA 510(k) clearance for ALLEGRO(TM) LUTEINIZING HORMONE IMMUNOA... by Nichols Institute Diagnostics. It is a Class 1 Chemistry device (product code CEP) cleared through the Traditional 510(k) pathway after a 33-day FDA review.

K881124 · Nichols Institute Diagnostics · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1988
Decision
33d
Days
Class 1
Risk

K881124 is an FDA 510(k) clearance for the ALLEGRO(TM) LUTEINIZING HORMONE IMMUNOASSAY. Classified as Radioimmunoassay, Luteinizing Hormone (product code CEP), Class I - General Controls.

Submitted by Nichols Institute Diagnostics (Los Angeles, US). The FDA issued a Cleared decision on April 18, 1988 after a review of 33 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1485 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Nichols Institute Diagnostics devices

Submission Details

510(k) Number K881124 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 16, 1988
Decision Date April 18, 1988
Days to Decision 33 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
55d faster than avg
Panel avg: 88d · This submission: 33d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CEP Radioimmunoassay, Luteinizing Hormone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1485
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CEP Radioimmunoassay, Luteinizing Hormone

All 67
Devices cleared under the same product code (CEP) and FDA review panel - the closest regulatory comparables to K881124.
ABBOTT IMX LH
K884138 · Abbott Laboratories · Nov 1988
PHASE II LH KIT
K882252 · Vitek Systems, Inc. · Aug 1988
AMERLITE LH-30 ASSAY, LAN.0082/2082 240/144 TEST
K880933 · Amersham Corp. · Jul 1988
IRMA-COUNT LH W/MONO. ANTIBODIES RKLH1,2,5
K874032 · Diagnostic Products Corp. · Dec 1987
O.P.T.(TM) OVULATION PREDICTION TEST
K870584 · Warner-Lambert Co. · Nov 1987
MEDIX BIOTECH LH ENZYME IMMUNOASSAY TEST KIT
K873668 · Medix Biotech, Inc. · Oct 1987